518.8500 -15.45 (-2.89%)
NSE Jan 23, 2026 15:31 PM
Volume: 41,018
 

518.85
-2.89%
Axis Direct
We expect Gross Margins to be impacted due to an increase in revenue share from non-regulated markets and an increase in raw material prices going onwards. Hence, we recommend a HOLD rating on the stock with a target price of INR 1,670 (PE 20x for FY23EPS).
Solara Active Pharma has lost -22.88% in the last 6 Months
More from Solara Active Pharma Sciences Ltd.
Recommended